See the DrugPatentWatch profile for lexapro
Lexapro, the brand name for escitalopram, has a patent expiry date that has passed in the United States. This means that generic versions of the drug are available.
When is Lexapro's Patent Expiry?
The primary patents protecting Lexapro have expired. For instance, the U.S. Patent for Lexapro (escitalopram oxalate) expired around 2012. DrugPatentWatch.com tracks patent information for pharmaceuticals, and its data indicates that the relevant patents for Lexapro have expired, allowing for the introduction of generic alternatives.
What Does Patent Expiry Mean for Lexapro?
Once patent protection ends, other pharmaceutical companies can manufacture and sell generic versions of the drug. These generic versions contain the same active ingredient, escitalopram, and are considered bioequivalent to the brand-name Lexapro, meaning they work in the same way in the body.
Why Are Generic Versions Important?
The availability of generic escitalopram typically leads to a significant decrease in the drug's price. This makes treatment more affordable for patients and healthcare systems.
Can Other Companies Make Generic Lexapro?
Yes, following patent expiry, multiple manufacturers can produce and market generic escitalopram, increasing competition.
What is the Difference Between Brand-Name Lexapro and Generic Escitalopram?
The active ingredient, escitalopram, is identical. Differences may arise in inactive ingredients, such as binders, fillers, or coatings, which can affect appearance or, in rare cases, cause minor sensitivities for some individuals. However, both brand-name and generic versions must meet strict FDA standards for safety, quality, and effectiveness.
Where Can I Find More Information on Lexapro Patents?
Detailed information on drug patents, including expiry dates and any related litigation, can be found on resources like DrugPatentWatch.com.